-
2
-
-
0027317628
-
Ultrastructure of retinal vessels in diabetic patients
-
Ishibashi, T., and Inomata, H. (1993) Ultrastructure of retinal vessels in diabetic patients. Br. J. Ophthalmol. 77, 574-578
-
(1993)
Br. J. Ophthalmol.
, vol.77
, pp. 574-578
-
-
Ishibashi, T.1
Inomata, H.2
-
3
-
-
0034933340
-
Early cellular and molecular changes induced by diabetes in the retina
-
Lorenzi, M., and Gerhardinger, C. (2001) Early cellular and molecular changes induced by diabetes in the retina. Diabetologia 44, 791-804
-
(2001)
Diabetologia
, vol.44
, pp. 791-804
-
-
Lorenzi, M.1
Gerhardinger, C.2
-
4
-
-
0028946006
-
Pericytes of newly formed vessels in experimental subretinal neovascularization
-
Ishibashi, T., Inomata, H., Sakamoto, T., and Ryan, S. J. (1995) Pericytes of newly formed vessels in experimental subretinal neovascularization. Arch. Ophthalmol. 113, 227-231
-
(1995)
Arch. Ophthalmol.
, vol.113
, pp. 227-231
-
-
Ishibashi, T.1
Inomata, H.2
Sakamoto, T.3
Ryan, S.J.4
-
5
-
-
34248224862
-
Time-lapse imaging of vitreoretinal angiogenesis originating from both quiescent and mature vessels in a novel ex vivo system
-
Murakami, T., Suzuma, K., Takagi, H., Kita, M., Ohashi, H., Watanabe, D., Ojima, T., Kurimoto, M., Kimura, T., Sakamoto, A., Unoki, N., and Yoshimura, N. (2006) Time-lapse imaging of vitreoretinal angiogenesis originating from both quiescent and mature vessels in a novel ex vivo system. Invest. Ophthalmol. Vis. Sci. 47, 5529-5536
-
(2006)
Invest. Ophthalmol. Vis. Sci.
, vol.47
, pp. 5529-5536
-
-
Murakami, T.1
Suzuma, K.2
Takagi, H.3
Kita, M.4
Ohashi, H.5
Watanabe, D.6
Ojima, T.7
Kurimoto, M.8
Kimura, T.9
Sakamoto, A.10
Unoki, N.11
Yoshimura, N.12
-
6
-
-
0025953395
-
Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels
-
Dvorak, H. F., Sioussat, T. M., Brown, L. F., Berse, B., Nagy, J. A., Sotrel, A., Manseau, E. J., Van de Water, L., and Senger, D. R. (1991) Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J. Exp. Med. 174, 1275-1278
-
(1991)
J. Exp. Med.
, vol.174
, pp. 1275-1278
-
-
Dvorak, H.F.1
Sioussat, T.M.2
Brown, L.F.3
Berse, B.4
Nagy, J.A.5
Sotrel, A.6
Manseau, E.J.7
Van De Water, L.8
Senger, D.R.9
-
7
-
-
41549109771
-
Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor
-
Hata, Y., Miura, M., Nakao, S., Kawahara, S., Kita, T., and Ishibashi, T. (2008) Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor. Jpn. J. Ophthalmol. 52, 16-23
-
(2008)
Jpn. J. Ophthalmol.
, vol.52
, pp. 16-23
-
-
Hata, Y.1
Miura, M.2
Nakao, S.3
Kawahara, S.4
Kita, T.5
Ishibashi, T.6
-
8
-
-
0027942607
-
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
-
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., Nguyen, H. V., Aiello, L. M., Ferrara, N., and King, G. L.(1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331, 1480-1487
-
(1994)
N. Engl. J. Med.
, vol.331
, pp. 1480-1487
-
-
Aiello, L.P.1
Avery, R.L.2
Arrigg, P.G.3
Keyt, B.A.4
Jampel, H.D.5
Shah, S.T.6
Pasquale, L.R.7
Thieme, H.8
Iwamoto, M.A.9
Park, J.E.10
Nguyen, H.V.11
Aiello, L.M.12
Ferrara, N.13
King, G.L.14
-
9
-
-
66149139466
-
Review of anti-VEGF therapy in proliferative diabetic retinopathy
-
Jardeleza, M. S., and Miller, J. W. (2009) Review of anti-VEGF therapy in proliferative diabetic retinopathy. Semin. Ophthalmol. 24, 87-92
-
(2009)
Semin. Ophthalmol.
, vol.24
, pp. 87-92
-
-
Jardeleza, M.S.1
Miller, J.W.2
-
10
-
-
78751693016
-
Blood vessel endothelial VEGFR-2 delays lymphangiogenesis: An endogenous trapping mechanism links lymph- and angiogenesis
-
Nakao, S., Zandi, S., Hata, Y., Kawahara, S., Arita, R., Schering, A., Sun, D., Melhorn, M. I., Ito, Y., Lara-Castillo, N., Ishibashi, T., and Hafezi-Moghadam, A. (2010) Blood vessel endothelial VEGFR-2 delays lymphangiogenesis: an endogenous trapping mechanism links lymph- and angiogenesis. Blood 117, 1081-1090
-
(2010)
Blood
, vol.117
, pp. 1081-1090
-
-
Nakao, S.1
Zandi, S.2
Hata, Y.3
Kawahara, S.4
Arita, R.5
Schering, A.6
Sun, D.7
Melhorn, M.I.8
Ito, Y.9
Lara-Castillo, N.10
Ishibashi, T.11
Hafezi-Moghadam, A.12
-
11
-
-
44949232186
-
In vivo imaging of endothelial injury in choriocapillaris during endotoxin-induced uveitis
-
Miyahara, S., Almulki, L., Noda, K., Nakazawa, T., Hisatomi, T., Nakao, S., Thomas, K. L., Schering, A., Zandi, S., Frimmel, S., Tayyari, F., Garland, R. C., Miller, J. W., Gragoudas, E. S., Masli, S., and Hafezi-Moghadam, A. (2008) In vivo imaging of endothelial injury in choriocapillaris during endotoxin-induced uveitis. FASEB J. 22, 1973-1980
-
(2008)
FASEB J.
, vol.22
, pp. 1973-1980
-
-
Miyahara, S.1
Almulki, L.2
Noda, K.3
Nakazawa, T.4
Hisatomi, T.5
Nakao, S.6
Thomas, K.L.7
Schering, A.8
Zandi, S.9
Frimmel, S.10
Tayyari, F.11
Garland, R.C.12
Miller, J.W.13
Gragoudas, E.S.14
Masli, S.15
Hafezi-Moghadam, A.16
-
12
-
-
77952298464
-
Superior sensitivity of novel molecular imaging probe: Simultaneously targeting two types of endothelial injury markers
-
Sun, D., Nakao, S., Xie, F., Zandi, S., Schering, A., and Hafezi-Moghadam, A. (2010) Superior sensitivity of novel molecular imaging probe: simultaneously targeting two types of endothelial injury markers. FASEB J. 24, 1532-1540
-
(2010)
FASEB J.
, vol.24
, pp. 1532-1540
-
-
Sun, D.1
Nakao, S.2
Xie, F.3
Zandi, S.4
Schering, A.5
Hafezi-Moghadam, A.6
-
13
-
-
77954609737
-
Novel molecular imaging approach for subclinical detection of iritis and evaluation of therapeutic success
-
Xie, F., Sun, D., Schering, A., Nakao, S., Zandi, S., Liu, P., and Hafezi-Moghadam, A. (2010) Novel molecular imaging approach for subclinical detection of iritis and evaluation of therapeutic success. Am. J. Pathol. 177, 39-48
-
(2010)
Am. J. Pathol.
, vol.177
, pp. 39-48
-
-
Xie, F.1
Sun, D.2
Schering, A.3
Nakao, S.4
Zandi, S.5
Liu, P.6
Hafezi-Moghadam, A.7
-
14
-
-
0035794311
-
L-selectin shedding regulates leukocyte recruitment
-
Hafezi-Moghadam, A., Thomas, K. L., Prorock, A. J., Huo, Y., and Ley, K. (2001) L-selectin shedding regulates leukocyte recruitment. J. Exp. Med. 193, 863-872
-
(2001)
J. Exp. Med.
, vol.193
, pp. 863-872
-
-
Hafezi-Moghadam, A.1
Thomas, K.L.2
Prorock, A.J.3
Huo, Y.4
Ley, K.5
-
15
-
-
79954571671
-
Noninvasive molecular imaging reveals role of PAF in leukocyte-endothelial interaction in LPS-induced ocular vascular injury
-
Garland, R. C., Sun, D., Zandi, S., Xie, F., Faez, S., Tayyari, F., Frimmel, S. A., Schering, A., Nakao, S., and Hafezi-Moghadam, A. (2011) Noninvasive molecular imaging reveals role of PAF in leukocyte-endothelial interaction in LPS-induced ocular vascular injury. FASEB J. 25, 1284-1294
-
(2011)
FASEB J.
, vol.25
, pp. 1284-1294
-
-
Garland, R.C.1
Sun, D.2
Zandi, S.3
Xie, F.4
Faez, S.5
Tayyari, F.6
Frimmel, S.A.7
Schering, A.8
Nakao, S.9
Hafezi-Moghadam, A.10
-
16
-
-
63849248396
-
Treating diabetic retinopathy by inhibiting growth factor pathways
-
Frank, R. N. (2009) Treating diabetic retinopathy by inhibiting growth factor pathways. Curr. Opin. Investig. Drugs 10, 327-335
-
(2009)
Curr. Opin. Investig. Drugs
, vol.10
, pp. 327-335
-
-
Frank, R.N.1
-
17
-
-
33750597534
-
Diabetic retinopathy: Seeing beyond glucose-induced microvascular disease
-
Antonetti, D. A., Barber, A. J., Bronson, S. K., Freeman, W. M., Gardner, T. W., Jefferson, L. S., Kester, M., Kimball, S. R., Krady, J. K., LaNoue, K. F., Norbury, C. C., Quinn, P. G., Sandirasegarane, L., and Simpson, I. A. (2006) Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 55, 2401-2411
-
(2006)
Diabetes
, vol.55
, pp. 2401-2411
-
-
Antonetti, D.A.1
Barber, A.J.2
Bronson, S.K.3
Freeman, W.M.4
Gardner, T.W.5
Jefferson, L.S.6
Kester, M.7
Kimball, S.R.8
Krady, J.K.9
LaNoue, K.F.10
Norbury, C.C.11
Quinn, P.G.12
Sandirasegarane, L.13
Simpson, I.A.14
-
18
-
-
77954450065
-
An animal model of spontaneous metabolic syndrome: Nile grass rat
-
Noda, K., Melhorn, M. I., Zandi, S., Frimmel, S., Tayyari, F., Hisatomi, T., Almulki, L., Pronczuk, A., Hayes, K. C., and Hafezi-Moghadam, A. (2010) An animal model of spontaneous metabolic syndrome: Nile grass rat. FASEB J. 24, 2443-2453
-
(2010)
FASEB J.
, vol.24
, pp. 2443-2453
-
-
Noda, K.1
Melhorn, M.I.2
Zandi, S.3
Frimmel, S.4
Tayyari, F.5
Hisatomi, T.6
Almulki, L.7
Pronczuk, A.8
Hayes, K.C.9
Hafezi-Moghadam, A.10
-
19
-
-
84901020487
-
Retinopathy in a novel model of metabolic syndrome and type 2 diabetes: New insight on the inflammatory paradigm
-
Noda, K., Nakao, S., Zandi, S., Sun, D., Hayes, K. C., and Hafezi-Moghadam, A. (2014) Retinopathy in a novel model of metabolic syndrome and type 2 diabetes: new insight on the inflammatory paradigm. FASEB J. 28, 2038-2046
-
(2014)
FASEB J.
, vol.28
, pp. 2038-2046
-
-
Noda, K.1
Nakao, S.2
Zandi, S.3
Sun, D.4
Hayes, K.C.5
Hafezi-Moghadam, A.6
-
20
-
-
2142660144
-
A novel mouse-driven ex vivo flow chamber for the study of leukocyte and platelet function
-
Hafezi-Moghadam, A., Thomas, K. L., and Cornelssen, C. (2004) A novel mouse-driven ex vivo flow chamber for the study of leukocyte and platelet function. Am. J. Physiol. Cell. Physiol. 286, C876-892
-
(2004)
Am. J. Physiol. Cell. Physiol.
, vol.286
, pp. C876-C892
-
-
Hafezi-Moghadam, A.1
Thomas, K.L.2
Cornelssen, C.3
-
21
-
-
84874409910
-
Retinal vascular caliber as a biomarker for diabetes microvascular complications
-
Ikram, M. K., Cheung, C. Y., Lorenzi, M., Klein, R., Jones, T. L., and Wong, T. Y. (2013) Retinal vascular caliber as a biomarker for diabetes microvascular complications. Diabetes Care 36, 750-759
-
(2013)
Diabetes Care
, vol.36
, pp. 750-759
-
-
Ikram, M.K.1
Cheung, C.Y.2
Lorenzi, M.3
Klein, R.4
Jones, T.L.5
Wong, T.Y.6
-
22
-
-
0035255002
-
In vivo activities of mutants of vascular endothelial growth factor (VEGF) with differential in vitro activities
-
Leenders, W., van Altena, M., Lubsen, N., Ruiter, D., and De Waal, R. (2001) In vivo activities of mutants of vascular endothelial growth factor (VEGF) with differential in vitro activities. Int. J. Cancer 91, 327-333
-
(2001)
Int. J. Cancer
, vol.91
, pp. 327-333
-
-
Leenders, W.1
Van Altena, M.2
Lubsen, N.3
Ruiter, D.4
De Waal, R.5
|